Youri Lee

发表

Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.

Yu-Jin Jung, D. Pérez, Jefferson J. S. Santos, 2019, Virology.

CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus

Zhen Bian, Yu-Na Lee, Young‐Tae Lee, 2016, Journal of Virology.

Environmental Cadmium Enhances Lung Injury by Respiratory Syncytial Virus Infection.

Dean P. Jones, Yu-Jin Jung, Y. Go, 2019, The American journal of pathology.

Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.

Yu-Jin Jung, Yu-Na Lee, Min-chul Kim, 2020, Virology.

Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Immune network.

Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge

M. Prausnitz, B. Graham, M. Song, 2018, PloS one.

Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells

Yu-Jin Jung, Yu-Na Lee, Young‐Tae Lee, 2015, PloS one.

Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine

Yu-Jin Jung, Yu-Na Lee, Young‐Tae Lee, 2017, The Journal of Immunology.

Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.

Yu-Jin Jung, Yu-Na Lee, Young‐Tae Lee, 2015, Virology.

Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses

Yu-Jin Jung, B. Seong, Bao-Zhong Wang, 2022, Molecular therapy. Methods & clinical development.

Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern

B. Golding, S. Khurana, H. Golding, 2021, iScience.

Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19

B. Golding, S. Khurana, H. Golding, 2021, bioRxiv.

Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus

Hyo-Jick Choi, Young‐Tae Lee, Min-chul Kim, 2018, Vaccines.

Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells

T. Denning, Yu-Jin Jung, Young‐Tae Lee, 2016, Journal of Virology.

Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins.

Yu-Jin Jung, Yu-Na Lee, Young‐Tae Lee, 2017, Journal of biomedical nanotechnology.

Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells

Young‐Tae Lee, Min-chul Kim, Ki-hye Kim, 2015, Journal of Virology.

Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.

Yu-Jin Jung, Bao-Zhong Wang, Young‐Tae Lee, 2019, Vaccine.

MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine

Yu-Jin Kim, Young‐Tae Lee, Ki-hye Kim, 2018, Antiviral research.

Natural killer cells contribute to enhanced respiratory disease after oil-in-water emulsion adjuvanted vaccination against respiratory syncytial virus and infection

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2021, Human vaccines & immunotherapeutics.

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.

Yu-Jin Jung, L. Rudenko, I. Isakova-Sivak, 2019, Antiviral research.

Impact of convalescent plasma therapy on SARS CoV-2 antibody profile in COVID-19 patients.

S. Khurana, H. Golding, Juanjie Tang, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients

S. Khurana, H. Golding, Juanjie Tang, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

ScholarWorks @ Georgia State University ScholarWorks @ Georgia State University Systems Biology from Virus to Humans Systems Biology from Virus to Humans

Yu-Jin Jung, Yu-Jin Kim, Ki-hye Kim, 2022 .

SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women

M. Sajadi, S. Khurana, D. Chertow, 2022, eBioMedicine.

Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex

S. Khurana, H. Golding, T. Ross, 2021, EBioMedicine.

Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus

Yu-Jin Jung, Yu-Na Lee, Ki-hye Kim, 2020, Vaccines.

Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution

M. Kiso, Y. Kawaoka, M. Saito, 2021, Science Advances.

Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients

S. Khurana, H. Golding, Juanjie Tang, 2021, Nature Communications.

Systems biology from virus to humans

Yu-Jin Jung, Yu-Jin Kim, Ki-hye Kim, 2015, Journal of Analytical Science and Technology.

Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine–Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019

S. Khurana, Juanjie Tang, Youri Lee, 2022, The Journal of infectious diseases.

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses

Young‐Tae Lee, Min-chul Kim, Ki-hye Kim, 2018, PloS one.

Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform

F. Quan, Young‐Tae Lee, Min-chul Kim, 2019, Immune network.

Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Virology.

Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes

Yu-Jin Jung, L. Rudenko, I. Isakova-Sivak, 2020, Vaccines.

The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.

Yu-Jin Jung, B. Seong, Young‐Tae Lee, 2019, Antiviral research.

EFFECTS OF VACCINE PLATFORMS AND ADJUVANTS ON PROTECTIVE EFFICACY AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS

Youri Lee, 2018 .

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.

Yu-Jin Jung, Yu-Jin Kim, Young‐Tae Lee, 2016, Virology.

Natural Killer and CD8 T Cells Contribute to Protection by Formalin Inactivated Respiratory Syncytial Virus Vaccination under a CD4-Deficient Condition

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2020, Immune network.

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.

B. Graham, Young‐Tae Lee, Ki-hye Kim, 2019, Virology.

Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Human vaccines & immunotherapeutics.

Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles.

Yu-Jin Jung, Ki-hye Kim, Sang-Moo Kang, 2019, Vaccine.

Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Human vaccines & immunotherapeutics.

SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19

S. Lapp, S. Khurana, Juanjie Tang, 2021, Nature Immunology.

Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.

Yu-Jin Jung, Xuguang Li, Yu-Jin Kim, 2019, Virology.

Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters

B. Golding, S. Khurana, H. Golding, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice.

Yu-Jin Jung, Young‐Tae Lee, Min-chul Kim, 2020, Vaccine.

Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2–infected individuals reveal unlinked immune signatures

S. Khurana, H. Golding, Juanjie Tang, 2021, Science advances.

Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report

B. Golding, S. Khurana, H. Golding, 2021, Annals of the Rheumatic Diseases.

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain

S. Khurana, H. Golding, Juanjie Tang, 2021, EMBO molecular medicine.

Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Human vaccines & immunotherapeutics.